Skip to main content
. 2012 Nov 12;15(6):485–502. doi: 10.1111/dom.12025

Figure 2.

Figure 2

Self-monitored blood glucose concentration in patients receiving insulin glargine in combination with either placebo or exenatide twice daily for 30 weeks. Values are least-squares mean ± standard error. *p < 0.01, **p < 0.001 for between-group comparison. Adapted with permission from 52.